Dr. Ellie Juarez is the Market Segment Manager for Oncology at Oxford Nanopore Technologies, leveraging her extensive expertise in cancer genomics and medical genetics. She plays a key role in advancing oncology assays, empowering researchers to tackle complex biological questions with nanopore sequencing. Dr. Juarez has held multiple leadership roles in the biotech industry, driving innovation in product development, applications, and corporate strategy to accelerate advancements in cancer research.
Wednesday, 18 June 2025
| Time |
Session |
|
|
14:30
15:15
|
-
Unlocking Novel Cancer Biology with Multiomic Insights, Introduction by Chair/ Moderator
-
Bridging genotype and phenotype through single-cell and single-molecule multi-omics
-
Tumour heterogeneity and clonal selection of ecDNA at single-cell level
Auditorium VIII
|
